CCX168
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CCX168, covering 2023-08-01 to 2023-08-16. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis [Phase 2]